Patents Represented by Attorney Mintz Levin Cohen Ferris Glovsky and Popeo, P.C.
-
Patent number: 7807415Abstract: The invention provides a method of producing a stable lymphocyte culture and methods of producing monoclonal antibodies.Type: GrantFiled: August 23, 2006Date of Patent: October 5, 2010Assignee: IQ Therapeutics BVInventors: Herman Groen, Hans H. Westra
-
Patent number: 7761379Abstract: A system and method for managing mass compromise of financial transaction devices is disclosed. A method includes maintaining a summary of a transaction history for a financial transaction device, and forming a device history profile based on the transaction history, the device history profile including predictive variables indicative of fraud associated with the financial transaction device. A method further includes generating a fraud score based on the predictive variables, the fraud score representing a likelihood that the financial transaction device is compromised will be used fraudulently.Type: GrantFiled: June 26, 2006Date of Patent: July 20, 2010Assignee: Fair Isaac CorporationInventors: Scott M. Zoldi, Liang Wang, Li Sun, Steven G. Wu
-
Patent number: 7750123Abstract: The invention provides scFv antibodies and monoclonal antibodies that neutralize SARS-CoV. Also provided are methods of treating and/or preventing a coronavirus-related disease or disorder such as SARS. The invention also provides methods of vaccinating a patient against SARS-CoV. Also provided are methods of diagnosing coronavirus-related diseases or disorders and methods of detecting the presence of a coronavirus in a sample. The invention additionally provides methods of screening for compounds that modulate the binding of SARS-CoV and the SARS-CoV receptor ACE2 as well as for compounds useful to treat SARS-CoV-related diseases or disorders.Type: GrantFiled: November 24, 2004Date of Patent: July 6, 2010Assignee: Dana Farber Cancer Institute, Inc.Inventors: Wayne Marasco, Jianhua Sui
-
Patent number: 7727535Abstract: The present invention provides compositions and methods for treating or preventing vascular-associated disorders.Type: GrantFiled: June 14, 2004Date of Patent: June 1, 2010Assignee: WyethInventors: Gray Shaw, Dianne Sako, Ravindra Kumar, Jin Xu
-
Patent number: 7714100Abstract: Novel markers for cardiac disease that are both sensitive and accurate. These markers are differentially and/or specifically expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of cardiac disease, including pathology and/or damage, including acute and/or chronic damage. The markers of the present invention, alone or in combination, show a high degree of differential detection between cardiac disease states and non-cardiac disease states.Type: GrantFiled: October 29, 2007Date of Patent: May 11, 2010Assignee: Compugen LTDInventors: Yossi Cohen, Alexander Diber, Amir Toporik, Sarah Pollock, Zurit Levine, Michal Ayalon-Soffer, Gad S. Cojocaru, Amit Novik, Guy Kol, Osnat Sella-Tavor, Shira Walach, Shirley Sameah-Greenwald, Dvir Dahary, Ronen Shemesh
-
Patent number: 7711635Abstract: A system and method is provided that provides tools to consumers to help consumers understand their credit scores and how to take action to improve their credit scores. A system and method for each of and for a combination of a score estimating tool, a best action simulation tool, an easy error correction tool, and a score improvement tool are provided.Type: GrantFiled: February 27, 2006Date of Patent: May 4, 2010Assignee: Fair Isaac CorporationInventors: Michael Scott Steele, Ethan J. Dornhelm, Sharon Hatcher Tilley, Jeffrey Jue, Edward Koichi McAvoy
-
Patent number: 7691996Abstract: This invention relates to antisense oligonucleotides that target mRNAs in cells as substrates for the cellular enzyme RNase H and thereby cause specific degradation of the targeted mRNA. The oligonucleotides have three components: an RNase H activating region, a complementary region and 3? and 5? ends. The invention optimizes each of the components to resist intracellular nucleases, to increase hybridization to target mRNA, to specifically inactivate target mRNA in cells, and to decrease cytotoxicity.Type: GrantFiled: January 14, 2005Date of Patent: April 6, 2010Assignees: Lakewood-Amedex, Sequitur, Inc.Inventors: Amy Arrow, Roderic M. K. Dale, Tod Mitchell Woolf
-
Patent number: 7635161Abstract: A seat includes a bladder assembly having a plurality of pneumatic bladders arranged one within another. The compressibility of each pneumatic bladder is based at least in part on a pressure within the pneumatic bladder, and/or on a thickness of an outer layer that defines the shape of the pneumatic bladder. In a configuration, an inner bladder is inflatable independently from an outer bladder, for adjustable, targeted support and compressibility.Type: GrantFiled: May 27, 2008Date of Patent: December 22, 2009Assignee: Air Seat Technologies, Inc.Inventor: Robert Donaghey
-
Patent number: 7621851Abstract: An aquatic exercise device (100) includes a cuff strap (102) for fastening a plurality of fins (106) to a user's leg. The cuff strap (102) is configured to position the plurality of fins (102) to extend outwardly form an interior of the cuff strap (102) when the cuff strap (102) is fastened to an ankle area of the user's leg. The plurality of fins (106) provide resistance in a direction opposite to the direction of motion of the user's foot when the aquatic exercise device (100) is moved through water.Type: GrantFiled: April 28, 2006Date of Patent: November 24, 2009Assignee: Aqualogix, Inc.Inventors: Tadlington A. Stout, James P. Cleary
-
Patent number: 7610880Abstract: Devices and methods for controlling an animal are disclosed. An animal control device includes a retractable leash assembly for being mounted to a collar or other harness. The retractable leash assembly has a retractable leash that is extendable from and retractable back to the collar via the retractable leash assembly. The retractable leash assembly includes a spool in a housing. The retractable leash is adapted to be wound around the spool in a retracted mode, and extendable from the spool in an extended mode.Type: GrantFiled: April 25, 2005Date of Patent: November 3, 2009Inventor: Anthony L. Lord
-
Patent number: 7607615Abstract: A kite brake and a kite that uses a brake are disclosed. The brake includes a spring-loaded standoff that is biased to push a top surface of a sail of the kite away from a strut of the kite when an air pressure on the bottom surface of the sail is less than a bias force of the spring. The brake can be deployed by operation of the kite, or simply based on a removal of the air pressure.Type: GrantFiled: January 6, 2006Date of Patent: October 27, 2009Assignee: Revolution Enterprises, Inc.Inventor: Joseph Hadzicki
-
Patent number: 7105150Abstract: Enriched neural stem and progenitor cell populations, and methods for identifying, isolating and enriching for neural stem cells using reagent that bind to cell surface markers, are provided.Type: GrantFiled: February 23, 2001Date of Patent: September 12, 2006Assignee: StemCells California, Inc.Inventors: David W. Buck, Nobuko Uchida, Irving Weissman
-
Patent number: 6979454Abstract: A biologically active stick composition comprising a biologically active agent dissolved in a carrier system including an unsaturated fatty acid alcohol in mutual dissolution with an alkylene glycol as a solvent for said biologically active agent and a stiffening agent therefor, said stiffening agent imparting stick consistency to the composition, said alkylene glycol preferably being present in an amount of more than 12%. The composition can be prepared by dissolving the active agent in the solvent, combining the solution with the stiffening agent and shaping the formulation into a stick. The composition is especially intended for use as a medicament, preferably in the treatment of dermatological conditions, where it has been found to possess outstanding bioavailability properties.Type: GrantFiled: April 29, 1997Date of Patent: December 27, 2005Assignee: Jagotec AGInventors: Åke Lindahl, Rickard Bryland
-
Patent number: 6123024Abstract: A stencil and stencil identification system in which the stencil carries a tagging device capable of storing data corresponding to characteristics of the stencil and the pattern of apertures formed in the stencil. The stencil with tagging device may be utilized in combination with a stencil printing device having a tag reader which reads information data stored within the tagging device and/or writes information into the tagging device relating to characteristics of the stencil or other criteria.Type: GrantFiled: January 14, 1999Date of Patent: September 26, 2000Assignee: Alpha Metals, Inc.Inventors: David Godfrey Williams, Raymond P. Sharpe, A. Jason Mirabito
-
Patent number: D607325Type: GrantFiled: September 5, 2008Date of Patent: January 5, 2010Assignee: Ivera Medical CorporationInventors: Bobby Rogers, Paul DiPerna
-
Patent number: D640009Type: GrantFiled: January 27, 2010Date of Patent: June 14, 2011Assignee: Richardson Capital, Inc.Inventor: Raymond Kevin Richardson